Published in J Virol on January 01, 1995
Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol (1995) 1.16
Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J Virol (1996) 1.02
Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain. J Gene Med (2008) 0.93
Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells. PLoS One (2013) 0.84
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften (1971) 13.09
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science (1985) 10.71
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
INTERFERENCE OF INACTIVE VIRUS WITH THE PROPAGATION OF VIRUS OF INFLUENZA. Science (1943) 10.31
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell (1989) 9.66
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
A molecular clone of HTLV-III with biological activity. Nature (1985) 8.30
Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A (1986) 8.06
Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell (1989) 7.46
Defective viral particles and viral disease processes. Nature (1970) 7.24
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol (1990) 6.73
Retroviral recombination and reverse transcription. Science (1990) 6.27
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Recovery of avian sarcoma virus from tumors induced by transformation-defective mutants. J Exp Med (1977) 4.79
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell (1989) 4.40
Defective interfering viruses. Annu Rev Microbiol (1973) 4.21
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04
Genetic variation in AIDS viruses. Cell (1986) 3.68
Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61
Gene therapy. Intracellular immunization. Nature (1988) 3.60
Incomplete forms of influenza virus. Adv Virus Res (1954) 3.05
Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature (1989) 2.91
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science (1988) 2.86
Origin and replication of defective interfering particles. Curr Top Microbiol Immunol (1981) 2.69
Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc Natl Acad Sci U S A (1989) 2.63
Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell (1989) 2.33
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol (1986) 1.83
High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. J Virol (1990) 1.83
A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses (1988) 1.80
Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr (1985) 1.76
Determination of the mutation rate of a retrovirus. J Virol (1988) 1.75
Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol (1991) 1.74
Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science (1989) 1.69
The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol (1987) 1.67
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A (1990) 1.55
Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J Virol (1989) 1.48
Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression. J Virol (1991) 1.26
Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Proc Natl Acad Sci U S A (1991) 1.24
Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun (1973) 1.21
Rift Valley Fever virus in mice. IV. Incomplete virus; its production and properties. Br J Exp Pathol (1956) 1.20
Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med (1990) 1.13
Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology (1977) 1.12
Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells. J Virol Methods (1991) 1.11
Generation of defective virus after infection of newborn rats with reovirus. J Virol (1976) 1.11
Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. J Gen Virol (1978) 1.09
Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol (1983) 1.07
Defective interfering virus particles modulate virulence. J Virol (1985) 1.04
Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J (1994) 1.04
Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change. J Exp Med (1979) 0.90
Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. J Virol (1993) 0.85
Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells. J Virol (1991) 0.77
Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication. J Gen Virol (1984) 0.76
Weight of HIV. AIDS Res Hum Retroviruses (1992) 0.76
A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev (2007) 14.60
Evidence based policymaking. Policymakers may need to make a break with the past. BMJ (1995) 3.33
Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS (1989) 3.19
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol (1999) 2.65
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol (1997) 2.54
Properties and substrate of slow pathway exposed with a compact node targeted fast pathway ablation in rabbit atrioventricular node. J Cardiovasc Electrophysiol (2001) 2.12
Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol (1992) 1.84
Experience with 37 infants with tyrosinemia. Can Med Assoc J (1967) 1.69
AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells. Virology (1990) 1.64
Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet (1995) 1.64
Genetic identification of an endoproteinase encoded by the adenovirus genome. J Mol Biol (1983) 1.58
The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood (1988) 1.56
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med (1992) 1.50
The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology (1996) 1.45
Early postnatal lethality in Hoxa-5 mutant mice is attributable to respiratory tract defects. Dev Biol (1997) 1.44
The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol (1997) 1.42
Relative resistance to chlorine of poliovirus and coxsackievirus isolates from environmental sources and drinking water. Appl Environ Microbiol (1985) 1.40
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res (2000) 1.24
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest (1994) 1.22
Seventeenth-century European origins of hereditary diseases in the Saguenay population (Quebec, Canada). Hum Biol (1997) 1.15
Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res (1999) 1.12
Smoking cessation counseling practices of general practitioners in Montreal. Prev Med (2001) 1.10
Hormonal regulation of alpha1 foetoprotein. Nature (1975) 1.10
Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs. Antimicrob Agents Chemother (1991) 1.09
Support for the involvement of TPH2 gene in affective disorders. Mol Psychiatry (2004) 1.06
Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology (1997) 1.06
Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J Virol (1996) 1.02
Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J Lipid Res (1997) 0.99
Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol (1995) 0.98
Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection. J Virol (2001) 0.98
HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck. J Exp Med (1996) 0.98
Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J Biol Chem (1997) 0.96
Characterization of gangliosides in human uveal melanoma cells. Int J Cancer (1991) 0.95
Women with spinal cord injury and the impact of aging. Spinal Cord (2002) 0.95
[Congenital malformations due to accutane]. Can Med Assoc J (1985) 0.94
The effect of smoking cessation counselling in pregnant women: a meta-analysis of randomised controlled trials. BJOG (2011) 0.94
Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul Disord (1994) 0.93
Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants. J Biol Chem (1991) 0.93
Meesmann's corneal dystrophy: ultrastructural features. Can J Ophthalmol (1982) 0.92
Hepatitis A vaccination during an outbreak among gay men in Montréal, Canada, 1995-1997. J Epidemiol Community Health (2001) 0.92
Transcriptional interferences at the Hoxa4/Hoxa5 locus: importance of correct Hoxa5 expression for the proper specification of the axial skeleton. Dev Dyn (1998) 0.91
[Regional differential reproduction of women born in the Saguenay between 1860 and 1870]. Cah Que Demogr (1993) 0.91
[Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia]. Pathol Biol (Paris) (1973) 0.91
Apolipoprotein C-I expression in the brain in Alzheimer's disease. Neurobiol Dis (2001) 0.91
AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci (1997) 0.91
A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol (1995) 0.90
[Apert's syndrome (acrocephalo-syndactyly). A case with 1 abnormal chromosome]. Arch Fr Pediatr (1966) 0.90
X-linked ocular albinism: relative value of skin biopsy, iris transillumination and funduscopy in identifying affected males and carriers. Can J Ophthalmol (1981) 0.89
Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model. J Pharmacol Exp Ther (1996) 0.88
Aging and the word frequency effect: a lexical decision investigation. Neuropsychologia (1989) 0.88
Acute vertebral osteomyelitis complicating Streptococcus sanguis endocarditis. Ann Rheum Dis (1988) 0.88
Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I. Arterioscler Thromb Vasc Biol (1998) 0.88
Non-chromaffin paraganglioma of the kidney with distant metastases. Can Med Assoc J (1968) 0.87
Multiple cis-acting regulatory regions are required for restricted spatio-temporal Hoxa5 gene expression. Dev Dyn (1999) 0.86
The sands of the Sahara. Can J Ophthalmol (1998) 0.86
Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study. Ann N Y Acad Sci (1990) 0.86
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE. J Lipid Res (1997) 0.86
Evaluation of an inference-based approach to treating obsessive-compulsive disorder. Cogn Behav Ther (2005) 0.86
Mechanism of Kex2p inhibition by its proregion. FEBS Lett (2001) 0.85
Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56lck. Virology (1997) 0.85
Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS (1995) 0.84
Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis (1998) 0.84
Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol (1996) 0.84
Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve (1995) 0.84
Association of apolipoprotein E with alpha2-macroglobulin in human plasma. J Lipid Res (1998) 0.83
Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine. AIDS (1995) 0.82
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Metabolism (2001) 0.82
[Intergenerational transmission of reproductive behavior in Saguenay at the end of the 19th century]. Cah Que Demogr (1997) 0.82
Educational level and the word frequency effect: a lexical decision investigation. Brain Lang (1992) 0.82
The radiosensitivity of uveal melanoma cells and the cell survival curve. Graefes Arch Clin Exp Ophthalmol (1995) 0.82
[Protuberant dermatofibrosarcoma. Clinicopathological study of 30 cases with ultrastructure of 2 cases]. Union Med Can (1970) 0.81
Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2',3'-dideoxyinosine. AIDS (1994) 0.81
Determination of genotoxicity of the metabolites of the pesticides Guthion, Sencor, Lorox, Reglone, Daconil and Admire by 32P-postlabeling. Mol Cell Biochem (1997) 0.81
Expression of Hox A11 in the limb and the regeneration blastema of adult newt. Int J Dev Biol (1994) 0.80
Homeobox-containing genes in the newt are organized in clusters similar to other vertebrates. Gene (1992) 0.80
Assessment of surveillance of human West Nile virus infection in Quebec, 2003. Can Commun Dis Rep (2004) 0.80
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model. Toxicol Appl Pharmacol (1997) 0.80
Graded expression of Emx-2 in the adult newt limb and its corresponding regeneration blastema. J Mol Biol (1998) 0.80
Sibship stability of genotype and phenotype in myotonic dystrophy. Clin Genet (2002) 0.80
Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report. Am J Med (1992) 0.80
In vitro factors affecting the concentration of gamma-LpE (gamma-LpE) in human plasma. J Lipid Res (1998) 0.79
Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.79
Macular dystrophy of the cornea. Ultrastructure of two cases. Can J Ophthalmol (1973) 0.79
A semi-automated software tool to study treadmill locomotion in the rat: from experiment videos to statistical gait analysis. J Neurosci Methods (2010) 0.79
3-Hydroxy-3-methylglutaric acid: protective action in experimental atherosclerosis in rabbits. Atherosclerosis (1974) 0.79
Role of the compact node and its posterior extension in normal atrioventricular nodal conduction, refractory, and dual pathway properties. J Cardiovasc Electrophysiol (1999) 0.78
In vivo toxicity of foscarnet and zidovudine given alone or in combination. Toxicol Appl Pharmacol (1996) 0.78
Behavioral diagnosis of 30 to 60 year-old men in the Fabreville Heart Health Program. J Community Health (1995) 0.78
Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.78
Brother of CDO (BOC) expression in equine articular cartilage. Osteoarthritis Cartilage (2011) 0.77
Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine. Antimicrob Agents Chemother (1996) 0.77
Marital adjustment and depression. Psychopathology (1995) 0.77
Ultrastructure of a Wilms' tumour and myogenesis. J Pathol (1971) 0.77
[Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases]. Union Med Can (1977) 0.77
Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet. Antimicrob Agents Chemother (1995) 0.77
[Hereditary tyrosinemia. I. Clinical and biological study of 62 cases]. Pediatrie (1973) 0.77
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res (1999) 0.76
Genetic analysis of genealogies in mentally retarded autistic probands from Saguenay Lac-Saint-Jean (Quebec, Canada). Ann Genet (1996) 0.76